Reply to Kaye and Belley, “Third-generation cephalosporin-resistant Enterobacterales are critical priority pathogens, too!”
Main Authors: | Butler, MS, Gigante, V, Sati, H, Paulin, S, Al-Sulaiman, L, Rex, JH, Fernandes, P, Arias, CA, Paul, M, Thwaites, GE, Czaplewski, L, Alm, RA, Lienhardt, C, Spigelman, M, Silver, LL, Ohmagari, N, Kozlov, R, Harbarth, S, Beyer, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society for Microbiology
2022
|
Similar Items
-
Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed.
by: Butler, MS, et al.
Published: (2022) -
Analysis of the clinical antibacterial and antituberculosis pipeline
by: Theuretzbacher, U, et al.
Published: (2018) -
Colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in hospitalized patients in Botswana
by: Naledi Betsi Mannathoko, et al.
Published: (2023-06-01) -
Resistance to extended-spectrum cephalosporins in Escherichia coli and other Enterobacterales from Canadian turkeys.
by: Jonathan Moffat, et al.
Published: (2020-01-01) -
Resistance to extended-spectrum cephalosporins in Escherichia coli and other Enterobacterales from Canadian turkeys
by: Jonathan Moffat, et al.
Published: (2020-01-01)